Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kah-Whye Peng

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Scientific Reports|September 23, 2018
New transgenic NIS reporter rats for longitudinal tracking of fibrogenesis by high-resolution imagingBethany Brunton, Lukkana Suksanpaisan, Hongtao Li, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 9, 2014
Noninvasive 3-dimensional imaging of liver regeneration in a mouse model of hereditary tyrosinemia type 1 using the sodium iodide symporter geneRaymond D Hickey, Shennen A Mao, Bruce Amiot, et al.
Molecular Cancer Therapeutics|November 22, 2017
Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine CancerShruthi Naik, Gina D Galyon, Nathan J Jenks, et al.
Cancer Research|December 21, 2006
Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificityCory Allen, Sompong Vongpunsawad, Takafumi Nakamura, et al.
Journal of Virology|August 30, 2008
In vitro and in vivo properties of adenovirus vectors with increased affinity to CD46Hongjie Wang, Ying Liu, Zongyi Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 6, 2013
DARPin-targeting of measles virus: unique bispecificity, effective oncolysis, and enhanced safetyKatrin Friedrich, Jan Rh Hanauer, Steffen Prüfer, et al.
Mbio|January 9, 2024
Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivityMiguel Á Muñoz-Alía, Rebecca A Nace, Baskar Balakrishnan, et al.
Molecular Therapy. Methods & Clinical Development|September 12, 2022
Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an <i>H</i> <i>.</i> <i>pylori</i> immunostimulatory bacterial transgeneKimberly B Viker, Michael B Steele, Ianko D Iankov, et al.
Cancer Research Communications|June 22, 2026
Phase 1 study of oncolytic virus VV1 as monotherapy or in combination with avelumab in patients with relapsed refractory solid tumorsJaime R Merchan, Manish R Patel, Timothy P Cripe, et al.
Molecular Therapy Oncolytics|August 26, 2020
Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic CancersBolni Marius Nagalo, Camilo Ayala Breton, Yumei Zhou, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Scientific Reports|September 23, 2018
New transgenic NIS reporter rats for longitudinal tracking of fibrogenesis by high-resolution imagingBethany Brunton, Lukkana Suksanpaisan, Hongtao Li, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 9, 2014
Noninvasive 3-dimensional imaging of liver regeneration in a mouse model of hereditary tyrosinemia type 1 using the sodium iodide symporter geneRaymond D Hickey, Shennen A Mao, Bruce Amiot, et al.
Molecular Cancer Therapeutics|November 22, 2017
Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine CancerShruthi Naik, Gina D Galyon, Nathan J Jenks, et al.
Cancer Research|December 21, 2006
Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificityCory Allen, Sompong Vongpunsawad, Takafumi Nakamura, et al.
Journal of Virology|August 30, 2008
In vitro and in vivo properties of adenovirus vectors with increased affinity to CD46Hongjie Wang, Ying Liu, Zongyi Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 6, 2013
DARPin-targeting of measles virus: unique bispecificity, effective oncolysis, and enhanced safetyKatrin Friedrich, Jan Rh Hanauer, Steffen Prüfer, et al.
Mbio|January 9, 2024
Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivityMiguel Á Muñoz-Alía, Rebecca A Nace, Baskar Balakrishnan, et al.
Molecular Therapy. Methods & Clinical Development|September 12, 2022
Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an <i>H</i> <i>.</i> <i>pylori</i> immunostimulatory bacterial transgeneKimberly B Viker, Michael B Steele, Ianko D Iankov, et al.
Cancer Research Communications|June 22, 2026
Phase 1 study of oncolytic virus VV1 as monotherapy or in combination with avelumab in patients with relapsed refractory solid tumorsJaime R Merchan, Manish R Patel, Timothy P Cripe, et al.
Molecular Therapy Oncolytics|August 26, 2020
Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic CancersBolni Marius Nagalo, Camilo Ayala Breton, Yumei Zhou, et al.
Pageof 12